Automated Breast Ultrasound System Market Segments, Opportunity, Growth and Forecast by End-Use Industry 2015-2025

Automated Breast Ultrasound System Market: Rising Awareness and Government Advocation Fuelling Growth: Global Industry Analysis and Opportunity Assessment 2015-2025

With the rapid and wide spread of the coronavirus pandemic, the automated breast ultrasound system market is facing a moderate slump in the short term. Breast ultrasound procedures are largely considered to be elective procedures, which have been postponed during the pandemic to minimize the risk of the contagion. This trend will reduce demand in the near future. However, automation tech helps in remote screening solutions, which could potentially sustain operations during the crisis period.

"Factors such as increased cases of obesity, hormone replacement therapies, age risks, and drop in childbirth, have increased rates of breast cancer in recent years. Consequently, the demand for automated breast ultrasound systems has gone up significantly. These trends are likely to continue into the foreseeable future," says the FMI analyst.

To Get Sample Copy of Report Visit @

Automated Breast Ultrasound System - Primary Takeaways

Automated breast volume scanners will account for major revenue share owing to accuracy in lactiferous ducts.
Diagnostic imaging centres are the primary end users of automated breast ultrasound systems, aided by infrastructure modernization drives.
North America is a key market for automated breast ultrasound systems, aided by widespread cancer awareness initiatives. Asia Pacific is gaining ground supported by government expenditure on healthcare.

Automated Breast Ultrasound System - Growth Factors

Rapid rise in breast cancer cases, among the female demographic is a major growth driver.
Tech advances in supplemental cancer detection technologies is bolstering screening outcomes, and device adoption.

Automated Breast Ultrasound System - Major Constraints

High costs and shortage of trained professionals are major challenges to market growth.
Lack of awareness about automated breast ultrasound systems, particularly in developing economies restrains market growth.

For More Details, Ask Analyst @

The Projected Impact of COVID-19

The ongoing coronavirus pandemic is expected to have a moderate impact on the operations of the automated breast ultrasound systems market. Most countries have designated breast ultrasound procedures as electives, and are encouraging patients and healthcare professionals to postpone such activities for non-urgent cases, for the near future, in a bid to restrict the spread of the contagion. Recovery of the market is likely to be strong owing to the rising global number of breast cancer cases.

Competition Landscape

The automated breast ultrasound system market comprises players including but not limited to SonoCine Inc., GE Electric Co., Hitachi Ltd., and Siemens AG. Market players are pushing for product launches with tech advancements. For instance, GE Healthcare has developed an FDA-approved, automated breast ultrasound systems aimed towards the diagnosis of cancer in dense breast tissue.

Download Methodology of this Report @

More about the Study

The FMI study provides detailed insights on automated breast ultrasound systems. The market is broken down in terms of product (automated breast volume scanner and automated breast ultrasound systems), and end user (diagnostic imaging centers and hospitals) across seven key regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA).

Explore FMI's Coverage of the Healthcare, Pharmaceuticals, and Medical Devices Industry

Wearable Medical Devices Market

Pharmacovigilance Market

Pharmaceutical Lipids Market

Contact Info:
Name: Abhishek Budholiya
Email: Send Email
Organization: Future Market Insights

Release ID: 89007116